RE:RE:New Press Release - Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary ProductsNo dilution, STEM was a Kane's subsidiary so Dechra bought 100% of STEM's shares 1/3 from Ecuphar NV (Animalcare) and 2/3 from Kane.
MirrorWorldMan wrote: Did this transaction result in dilution and a loss of STEM in order to get proceeds.?. here is why I ask, "The Transaction was completed by way of a share purchase agreement between Kane, STEM, Ecuphar NV and Dechra dated April 12, 2024."